Clinical trial
Depakote ER in Bipolar Depression
NCT00186186 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186186 |
|---|---|
| Title | Depakote ER in Bipolar Depression |
| Official title | Depakote ER in Bipolar Depression |
| Lead sponsor | Stanford University, Other |
| Collaborators | Abbott Industry National Alliance for Research on Schizophrenia and Depression |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression, Bipolar |
| Intervention type | Drug |
| Interventions | Depakote ER |
| Enrollment | 28 |
| Start date | Jan 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: